151 related articles for article (PubMed ID: 31191656)
1. Engineering of L-Plastin Peptide-Loaded Biodegradable Nanoparticles for Sustained Delivery and Suppression of Osteoclast Function In Vitro.
Majumdar S; Wadajkar AS; Aljohani H; Reynolds MA; Kim AJ; Chellaiah M
Int J Cell Biol; 2019; 2019():6943986. PubMed ID: 31191656
[TBL] [Abstract][Full Text] [Related]
2. Peptidomimetic inhibitors of L-plastin reduce the resorptive activity of osteoclast but not the bone forming activity of osteoblasts in vitro.
Chellaiah MA; Majumdar S; Aljohani H
PLoS One; 2018; 13(9):e0204209. PubMed ID: 30248139
[TBL] [Abstract][Full Text] [Related]
3. L-plastin phosphorylation regulates the early phase of sealing ring formation by actin bundling process in mouse osteoclasts.
Chellaiah MA; Ma T; Majumdar S
Exp Cell Res; 2018 Nov; 372(1):73-82. PubMed ID: 30244178
[TBL] [Abstract][Full Text] [Related]
4. L-Plastin deficiency produces increased trabecular bone due to attenuation of sealing ring formation and osteoclast dysfunction.
Chellaiah MA; Moorer MC; Majumdar S; Aljohani H; Morley SC; Yingling V; Stains JP
Bone Res; 2020; 8():3. PubMed ID: 31993243
[TBL] [Abstract][Full Text] [Related]
5. Peptidomimetic inhibitor of L-plastin reduces osteoclastic bone resorption in aging female mice.
Aljohani H; Stains JP; Majumdar S; Srinivasan D; Senbanjo L; Chellaiah MA
Bone Res; 2021 Apr; 9(1):22. PubMed ID: 33837180
[TBL] [Abstract][Full Text] [Related]
6. The actin-bundling protein L-plastin: a critical regulator of immune cell function.
Morley SC
Int J Cell Biol; 2012; 2012():935173. PubMed ID: 22194750
[TBL] [Abstract][Full Text] [Related]
7. Licorice isoliquiritigenin-encapsulated mesoporous silica nanoparticles for osteoclast inhibition and bone loss prevention.
Sun X; Zhang J; Wang Z; Liu B; Zhu S; Zhu L; Peng B
Theranostics; 2019; 9(18):5183-5199. PubMed ID: 31410209
[TBL] [Abstract][Full Text] [Related]
8. Exosomal Release of L-Plastin by Breast Cancer Cells Facilitates Metastatic Bone Osteolysis.
Tiedemann K; Sadvakassova G; Mikolajewicz N; Juhas M; Sabirova Z; Tabariès S; Gettemans J; Siegel PM; Komarova SV
Transl Oncol; 2019 Mar; 12(3):462-474. PubMed ID: 30583289
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
[TBL] [Abstract][Full Text] [Related]
10. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
Li Y; Pei Y; Zhang X; Gu Z; Zhou Z; Yuan W; Zhou J; Zhu J; Gao X
J Control Release; 2001 Apr; 71(2):203-11. PubMed ID: 11274752
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of ectopically expressed L-plastin enhances invasiveness of human melanoma cells.
Klemke M; Rafael MT; Wabnitz GH; Weschenfelder T; Konstandin MH; Garbi N; Autschbach F; Hartschuh W; Samstag Y
Int J Cancer; 2007 Jun; 120(12):2590-9. PubMed ID: 17290393
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of β-Sitosterol Loaded PLGA and PEG-PLA Nanoparticles for Effective Treatment of Breast Cancer: Preparation, Physicochemical Characterization, and Antitumor Activity.
Andima M; Costabile G; Isert L; Ndakala AJ; Derese S; Merkel OM
Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30445705
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation on Ser5 increases the F-actin-binding activity of L-plastin and promotes its targeting to sites of actin assembly in cells.
Janji B; Giganti A; De Corte V; Catillon M; Bruyneel E; Lentz D; Plastino J; Gettemans J; Friederich E
J Cell Sci; 2006 May; 119(Pt 9):1947-60. PubMed ID: 16636079
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of bone resorption in vitro by a peptide containing the cadherin cell adhesion recognition sequence HAV is due to prevention of sealing zone formation.
Ilvesaro JM; Lakkakorpi PT; Väänänen HK
Exp Cell Res; 1998 Jul; 242(1):75-83. PubMed ID: 9665804
[TBL] [Abstract][Full Text] [Related]
16. The Actin-Binding Protein Cofilin and Its Interaction With Cortactin Are Required for Podosome Patterning in Osteoclasts and Bone Resorption In Vivo and In Vitro.
Zalli D; Neff L; Nagano K; Shin NY; Witke W; Gori F; Baron R
J Bone Miner Res; 2016 Sep; 31(9):1701-12. PubMed ID: 27064822
[TBL] [Abstract][Full Text] [Related]
17. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
[TBL] [Abstract][Full Text] [Related]
18. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of osteoclast bone resorption activity through osteoprotegerin-induced damage of the sealing zone.
Song R; Gu J; Liu X; Zhu J; Wang Q; Gao Q; Zhang J; Cheng L; Tong X; Qi X; Yuan Y; Liu Z
Int J Mol Med; 2014 Sep; 34(3):856-62. PubMed ID: 25017214
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary targeting with biodegradable salbutamol-loaded nanoparticles.
Beck-Broichsitter M; Gauss J; Gessler T; Seeger W; Kissel T; Schmehl T
J Aerosol Med Pulm Drug Deliv; 2010 Feb; 23(1):47-57. PubMed ID: 19778266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
